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Abstract
In patients with Long-QT Syndrome (LQTS), mechanical abnormalities have been described. Recognition of these abnor-
malities could potentially be used in the diagnosis of LQTS, especially in the foetus where an ECG is not available and 
DNA-analysis is invasive. We aimed to develop and validate a marker for these mechanical abnormalities in children and to 
test its feasibility in foetuses as a proof of principle. We measured the myocardial contraction duration using colour Tissue 
Doppler Imaging (cTDI) in 41 LQTS children and age- and gender-matched controls. Children were chosen to develop and 
validate the measurement of the myocardial contraction duration, due to the availability of a simultaneously recorded ECG. 
Feasibility of this measurement in foetuses was tested in an additional pilot study among seven LQTS foetuses and eight 
controls. LQTS children had a longer myocardial contraction duration compared to controls, while there was no statistical 
difference in heart rate. Measuring the myocardial contraction duration in children had a high inter- and intra-observer validity 
and reliably correlated with the QT-interval. There was an area under the curve (AUC) of 0.71, and the optimal cut-off value 
showed an especially high specificity in diagnosing LQTS. Measuring the myocardial contraction duration was possible in all 
foetuses and had a high inter- and intra-observer validity (ICC = 0.71 and ICC = 0.88, respectively). LQTS foetuses seemed 
to have a longer myocardial contraction duration compared to controls. Therefore, a prolonged contraction duration may be 
a potential marker for the prenatal diagnosis of LQTS in the future. Further studies are required to support the measurement 
of the myocardial contraction duration as a diagnostic approach for foetal LQTS.
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Introduction
Congenital Long-QT syndrome (LQTS) in an inherited 
cardiac repolarization disorder, with a predisposition to 
malignant ventricular arrhythmias, that can precipitate syn-
cope, sudden cardiac arrest or sudden cardiac death [1]. 
The degree of impairment and dispersion of repolarization 
have been considered to play a role in the occurrence of 
these ventricular arrhythmias [2]. Although, patients with 
LQTS have a normal left ventricular function, several stud-
ies have shown mechanical abnormalities in the contrac-
tion and relaxation pattern in adult LQTS patients using 
M-Mode echocardiography,[3–5] continuous-wave Doppler 
images,[6] colour Tissue Doppler Imaging (cTDI) [7, 8] and 
Speckle Tracking [9–11]. One study has found mechanical 
dysfunction in children with the use of MRI [12]. These 
abnormalities were almost absent in healthy individuals, but 
prevalent among LQTS patients whereas in symptomatic 
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patients this was even more frequent, suggesting their poten-
tial value in the diagnosis and risk stratification in LQTS.
The use of the presence of mechanical abnormalities in the 
risk stratification for malignant cardiac arrhythmias in adult 
and paediatric LQTS patients is perhaps more promising than 
its use in diagnosing LQTS, since most LQTS patients can be 
diagnosed based on a high clinical suspicion using electro-
cardiographic features, clinical and family history or in the 
presence of a confirmed pathogenic mutation [13]. Diagnos-
ing LQTS prenatally is however challenging due to the lack 
of an accurate and comprehensible electrocardiogram (ECG), 
[14] the scarcity of foetal magnetocardiography, [15–18] and 
the invasiveness of DNA-analysis with a risk of miscarriage 
[19]. To date, foetal arrhythmias are diagnosed by echocardi-
ography providing accurate information about the atrial and 
ventricular contractions that indirectly reflect the P-wave and 
QRS-complex [20]. Unfortunately echocardiography cannot 
assess a derivative of the QT-interval.
However, diagnosing LQTS before birth is relevant as it 
is a cause of sudden infant death and sudden unexplained 
intrauterine death [14, 21, 22]. In addition, when LQTS is 
diagnosed during foetal life there are important clinical con-
sequences [14]. For instance, maternal QT-prolonging drugs 
frequently used during pregnancy and childbirth must be 
withheld, even if the mother does not suffer from LQTS. 
Furthermore, in case of foetal arrhythmias, some antiar-
rhythmic drugs that are usually given are contraindicated 
if the foetus has LQTS, e.g. amiodarone [23–25]. Lastly, a 
sinus bradycardia, 2:1 atrioventricular conduction or reduced 
beat to beat variability in the foetus can be attributed to the 
LQTS phenotype [26] instead of foetal distress. Hence, an 
accurate prenatal diagnosis of LQTS can avoid potentially 
unnecessary preterm deliveries or emergency caesarean sec-
tions for incorrectly presumed foetal distress.
Haugaa et  al. [8] used a combination of cTDI and a 
simultaneously recorded ECG to evaluate the mechanical 
abnormalities in adult LQTS patients, and found a prolonged 
myocardial contraction duration in these patients. As cTDI 
has proven to be feasible in foetuses, has already been used 
in the evaluation of foetal cardiac function in various preg-
nancy complications,[27–29] and has been shown to be reli-
able in the measurement of foetal time intervals,[30] it could 
potentially be used for the measurement of the myocardial 
contraction duration prenatally. However, this measurement 
then needs to be made in the absence of an ECG.
This study had three aims: Firstly, to assess the diagnostic 
value of measuring the myocardial contraction duration by 
measuring it in children and correlating it to the QT-interval 
on the ECG. Children were chosen due to the availability 
of a simultaneously recorded ECG. Secondly, we aimed to 
develop a technique for the measurement of the myocardial 
contraction duration without the need for a simultaneously 
recorded ECG in children and to test its diagnostic value. 
Lastly, we wished to test the feasibility of this developed 
technique of measuring the myocardial contraction dura-
tion without a simultaneously recorded ECG in a pilot study 
among foetuses as a proof of principle.
Methods
Study Population (Children)
This cross-sectional study included genotype-positive LQTS 
children under the age of 18 years, and age- and gender-
matched controls. LQTS was diagnosed based on a con-
firmed pathogenic mutation detected using conventional 
methods. Controls were referred for cardiac screening and 
a normal heart was confirmed after a clinical examination, 
ECG and echocardiography. The ECG and echocardiogram 
of the cases were performed during a regular follow-up visit 
and of the controls during a screening visit at the outpatient 
clinic of our hospital. The study was approved by the insti-
tutional Review Board.
Electrocardiogram (Children)
A 12-lead ECG was obtained in all subjects, either 
straight before or after echocardiography. All ECGs were 
digitalized, blinded and manually analysed by one inves-
tigator (ASV) using Image J 1.50i [National Institutes of 
Health, USA]. QT-intervals of three consecutive complexes 
were measured using the tangent method (QT-12ECG). Pre-
ceding RR-intervals were obtained (RR-12ECG), and the 
QTc-interval was calculated using the Bazett’s correction 
formula,[31] after the three consecutive complexes were 
averaged (QTc-12ECG).
Echocardiography (Children)
In all subjects an echocardiogram was obtained using Vivid 
7 [GE, Healthcare, Horten, Norway]. The shortening frac-
tion (SF) was calculated from the left ventricle end-diastolic 
and end-systolic diameters measured on M-mode. In addi-
tion, a two-dimensional guided cTDI recording was obtained 
by well-trained echocardiographers. All cTDI images were 
obtained with a frame rate of ≥ 95 frames per second from 
an apical four chamber view and analysed using commer-
cially offline available software [Q-Analysis, EchoPac®, 
GE] averaging three cycles with the cursor on the basal 
interventricular septum (IVS). The IVS was chosen because 
of its relative easy determination in the small foetal heart. 
The following parameters were assessed (Fig. 1):
 I. The myocardial contraction duration (CD) as 
described by Haugaa et al. [8], defined as the time 
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from start of R on the 3-lead ECG that was recorded 
throughout the cTDI procedure, to the end of the 
post-ejection velocity (PEV) at zero-crossing or to 
zero-crossing of the decreasing velocity slope in end-
systole when no positive PEV was present.
 II. RR-intervals on the 3-lead ECG (RR-3ECG) recorded 
throughout the cTDI procedure.
 III. The myocardial contraction duration blinded for the 
3-lead ECG recorded throughout the cTDI procedure 
 (CDblinded), defined as the time from the first positive 
velocity slope before peak ejection velocity (zero-
crossing), to the end of the PEV at zero-crossing or 
to zero-crossing of the decreasing velocity slope in 
end-systole when no positive PEV was present.
 IV. Cycle length (CL), defined as the time between the 
two successive troughs of the velocity slope in end-
systole, including the  CDblinded.
All parameters were measured blinded for subjects’ 
characteristics. It was ensured that there was sufficient time 
between the parameters unblinded (CD and RR-3ECG) 
and blinded for the 3-lead ECG recording throughout 
the cTDI procedure  (CDblinded and CL) in order to avoid 
recall. One observer (ASV) measured all the parameters 
and these measurements were used in the primary analy-
ses. A second observer (SC) measured the  CDblinded and 
CL to obtain inter-observer validity and the CD,  CDblinded 
and CL were re-measured by ASV in order to obtain intra-
observer validity.
Pilot Study (Foetuses)
The feasibility of measuring the  CDblinded and CL in foe-
tuses was tested in a pilot study among foetuses with pater-
nal or maternal genotype-positive LQTS, and healthy foe-
tuses with a normal heart on the echocardiogram. LQTS 
was diagnosed after birth if the family mutation was found.
In all foetuses a two-dimensional guided cTDI record-
ing was obtained by one foetal cardiologist (SC). The 
angle of insonation of the long axis of the heart was kept 
as small as possible, and recordings were made in the 
absence of foetal movement. Images were digitally saved 
with a frame rate of ≥ 130 frames per second. The cTDI 
recordings were analysed using Q-Analysis [EchoPac®, 
GE] averaging three cycles with the circular marker (diam-
eter 3 mm) on the basal  IVS. The  CDblinded and CL were 
measured blinded for subjects’ characteristics by two 
observers (ASV and SC) to obtain inter-observer validity 
and a repeated analysis was done only by ASV a week later 
to obtain intra-observer validity.
Fig. 1  Schematic figure of the 
echocardiography parameters. 
Red parameters were measured 
unblinded for the 3-lead ECG, 
blue parameters were measured 
blinded for the 3-lead ECG. RR-
3ECG RR-interval on the 3-lead 
ECG throughout cTDI record-
ing, CD myocardial contraction 
duration measured unblinded 
for the surface ECG, CDblinded 
myocardial contraction duration 
measured blinded for the sur-
face ECG, CL cycle length. 
s′ first-peak systolic velocity 
of the annulus, e′ early peak 
diastolic velocity, a′ late peak 
diastolic velocity
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Statistical Analysis
Clinical and echocardiographic characteristics were pre-
sented as frequencies (percentage) for categorical variables, 
mean (95% confidence intervals; CI) for continuous vari-
ables with an approximately symmetrical distribution and 
median (interquartiles) for continuous data with a skewed 
distribution. Differences between LQTS children and con-
trols were analysed as appropriate by a paired t-test or a 
Wilcoxon signed-rank test for continuous data, and by a 
McNemar’s test for binary data. Differences between LQTS 
foetuses and controls were only presented as an absolute 
mean difference based on either all the first or all the last 
echocardiograms of the foetuses. In children, a multiple lin-
ear regression was performed to correct the CD and  CDblinded 
for the heart rate (i.e. RR-3ECG and CL, respectively) strati-
fied by LQTS patients or controls.
Inter-method variability in children was defined between 
12-lead ECG and echocardiographic parameters, as well as 
between the CD and  CDblinded. The inter-method variability 
in children and the intra- and inter-observer validity for both 
children and foetuses were all expressed as correlation coef-
ficients estimated by a Pearson correlation or Spearman rank 
correlation test as appropriate, and the intra-class correlation 
coefficient (ICC) for multiple measurements based on a con-
sistency (inter-method variability and intra-observer valid-
ity) and two-way agreement (inter-observer validity) model 
according to Ciccheti [32] and Fleiss [33]. Bland–Altman 
analyses [34] were performed to assess bias and limits of 
agreement for the inter-method in children and the intra- and 
inter-observer validity for both the children and the foetuses.
Receiver-operating characteristic (ROC) curves were con-
structed to determine the area under the curve (AUC) and 
the sensitivity and specificity for specific cut-off values of 
the QT-12ECG, QTc-12ECG, CD and  CDblinded to identify 
LQTS children. The cut-off value of the QTc-interval was 
established at 460 ms [35] and the optimal cut-off value 
for both the CD and  CDblinded, was defined as the Youden’s 
index. The reliability of the cut-off values was validated 
using bootstrap resampling (n = 1.000) [36].
Sampling uncertainty was quantified via 95% confidence 
intervals (CI) and P values. A P value < 0.05 was consid-
ered to be statistically significant. Data were analysed with 




cTDI recordings were performed in 160 eligible sub-
jects until April 2017. Forty-one LQTS patients could 
appropriately be matched to controls with respect to age and 
gender (Table 1). The QTc-interval was prolonged in LQTS 
patients (P < 0.001) with an absolute mean difference of 
44 ms compared to the controls. LQTS patients were mainly 
diagnosed as a result of family screening (88%). There were 
five symptomatic LQTS patients, of whom only one had a 
QTc-interval > 460 ms at the time of the cTDI recording 
during follow-up. Of these five symptomatic patients, three 
patients were symptomatic before diagnosis. One had a syn-
copal event after waking up from a loud noise, 4 years before 
the data used in this study was obtained. Another patient 
had a syncope during cycling, within the same year as the 
collected ECG and echocardiogram in this study. Another 
patient had an event of near-drowning 2 years before the 
included ECG and echocardiogram. Two patients had a 
cardiac event after diagnosis. One patient had (pre)synco-
pal episodes after a nightmare, one year after our included 
data. In addition, there was one LQTS type 3 patient that 
had a sudden cardiac death during follow-up while he 
was treated with propranolol and mexiletine. A pacemaker 
and a subcutaneous implantable cardioverter defibrillator 
had to be explanted due to endocarditis and persistent furun-
culosis. The included ECG and echocardiogram were made 
4 years before his death. Four asymptomatic LQTS patients 
had a QTc-interval > 460 ms. In all the included subjects, 
Table 1  Clinical characteristics and echocardiographic parameters of 
the included children
RR-12ECG RR-interval on the  12-lead ECG, ms milliseconds, CI 
confidence interval, QT-12ECG QT-interval on the  12-lead ECG, 
QTc-12ECG QTc-interval on  the 12-lead ECG, SF shortening frac-
tion, CD myocardial contraction duration measured unblinded for the 
surface ECG, RR-3ECG RR-interval on  the 3-lead ECG throughout 
cTDI recording, CDblinded myocardial contraction duration measured 








Age, years (interquartiles) 11 (6–14) 11 (7–14) 0.775
Female, n (%) 15 (37) 15 (37) 0.118
RR-12ECG, ms (95% CI) 906 (838–974) 818 (760–876) 0.104
QT-12ECG, ms (95% CI) 407 (389–425) 347 (335–358) < 0.001
QTc-12ECG, ms (95% 
CI)
431 (422–441) 387 (381–392) < 0.001
SF, % (95% CI) 39 (39–41) 40 (39–42) 0.640
Beta-blocker therapy, 
n (%)
34 (83) 0 (0) 0.023
Echocardiographic parameters
CD, ms (95% CI) 420 (403–438) 383 (367–399) 0.005
RR-3ECG, ms (95% CI) 927 (855–999) 837 (768–905) 0.130
CDblinded, ms (95% CI) 412 (397–428) 373 (356–391) 0.004
CL, ms (95% CI) 927 (854–999) 836 (767–904) 0.126
1417Pediatric Cardiology (2018) 39:1413–1422 
1 3
there was a normal SF with no difference between the LQTS 
patients and controls (P = 0.640). The genotypes of the 
LQTS patients are shown in Supplementary Table 1.
Contraction Duration in Children
The CD and  CDblinded were both significantly prolonged 
in LQTS patients compared to controls, with an absolute 
mean difference of 37 ms (P = 0.005) and 39 ms (P = 0.004), 
respectively (Table 1). Though not statistically significant, 
LQTS patients had a longer RR-3ECG and CL compared 
to controls. However, after correction for RR-3ECG by a 
multiple linear regression analysis, the CD remained pro-
longed in LQTS patients compared to controls (P = 0.011). 
The same was found when the CDblinded was corrected for 
CL (P = 0.006).
Inter‑method Variability in Children
Inter-method variability between the 12-lead ECG and echo-
cardiographic parameters, and between the two echocardio-
graphic parameters CD and  CDblinded, are shown in Table 2. 
There was a high consistency between the RR-12ECG and 
RR-3ECG (ICC = 0.92, P < 0.001), indicating no major 
differences in heart rate between the 12-lead ECG and 
echocardiogram. In addition, there was a strong agreement 
between the QT-12ECG and CD (ICC = 0.87, P < 0.001). 
Inter-method variability between the  CDblinded and the 
12-lead ECG parameters showed similar results as the CD.
Comparing the two echocardiographic parameters, CD 
and  CDblinded, showed a high consistency (ICC = 0.87, 
P < 0.001) with a systematic error of 9 ms and a maximal 
difference of 77 ms. The Bland–Altman plot is shown in 
Fig. 2.
Table 2  Correlation and Intra-class correlation coefficients (ICC) and Bland–Altman analyses in children
CI confidence interval, ms milliseconds, RR-12ECG RR-interval on  the 12-lead ECG, RR-3ECG RR-interval on  the 3-lead ECG throughout 
cTDI recording, QT-12ECG QT-interval on the 12-lead ECG, CD myocardial contraction duration measured unblinded for  the surface ECG, 
QTc-12ECG QTc-interval on the 12-lead ECG, CDblinded myocardial contraction duration measured blinded for the surface ECG, CL cycle length 
measured blinded for the surface ECG
Correlation coefficient 
(95% CI)
P value ICC (95% CI) P value Mean difference in ms 
(± Limits of agree-
ment in ms)
12-lead ECG vs Echocardiographic parameters
RR-12ECG vs RR-3ECG 0.85 (0.78–0.90) < 0.001 0.92 (0.87–0.95) < 0.001 − 20 (± 240)
QT-12ECG vs CD 0.77 (0.67–0.85) < 0.001 0.87 (0.80–0.92) < 0.001 − 25 (± 76)
QTc-12ECG vs CD 0.36 (0.16–0.54) < 0.001 0.45 (0.15–0.65) 0.004 7 (± 111)
QT-12ECG vs  CDblinded 0.67 (0.53–0.77) < 0.001 0.80 (0.69–0.87) < 0.001 − 16 (± 91)
QTc-12ECG vs  CDblinded 0.28 (0.07–0.47) 0.009 0.38 (0.03–0.60) 0.017 16 (± 114)
Echocardiographic parameters
CD vs  CDblinded 0.77 (0.66–0.84) < 0.001 0.87 (0.80–0.92) < 0.001 9 (± 77)
Intra-observer validity
CD 0.92 (0.87–0.95) < 0.001 0.96 (0.93–0.97) < 0.001 − 8 (± 46)
CDblinded 0.89 (0.83–0.93) < 0.001 0.94 (0.91–0.97) < 0.001 1 (± 52)
CL 1.00 (1.00–1.00) < 0.001 1.00 (1.00–1.00) < 0.001 − 1 (± 28)
Inter-observer validity
CDblinded 0.84 (0.77–0.90) < 0.001 0.91 (0.84–0.94) < 0.001 11 (± 62)
CL 1.00 (1.00–1.00) < 0.001 1.00 (1.00–1.00) < 0.001 1 (± 21)
Fig. 2  Bland–Altman plot for the comparison of CD and  CDblinded in 
children. In grey the 95% confidence interval around the mean and 
the limits of agreement. In pink the regression lines. ms milliseconds
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Intra‑and Inter‑observer Validity in Children
The intra-observer validity was very high for measuring 
the CD (ICC = 0.96, P < 0.001) with a systematic error of 
8 ms (maximal difference 46 ms). The reproducibility for 
the  CDblinded had approximately the same magnitude as the 
CD (ICC = 0.94, P < 0.001) with a smaller systematic error 
(1 ms with a maximal difference of 52 ms). The inter-
observer validity for  CDblinded was also high (ICC = 0.91, 
P < 0.001). The intra- and inter-observer validity for CL 
was very high (for both ICC = 1.00 and P < 0.001) with 
for the intra-observer validity a systematic error of 1 ms 
(maximal difference 28 ms) and for the inter-observer 
validity a systematic error of 1 ms (maximal difference 
21 ms).
Sensitivity and Specificity in Children
There was an AUC of 0.71 (95% CI by bootstrapping 
0.47–0.71) for the CD and the optimal cut-off value of 
422 ms (95% CI by bootstrapping 371–448 ms) yielded a 
sensitivity of 61% (95% CI by bootstrapping 46–76%) and 
a specificity of 78% (95% CI by bootstrapping 63–90%) for 
the diagnosis of LQTS. The  CDblinded had a similar distinc-
tiveness compared to the CD. In this relatively asympto-
matic group of LQTS patients, the optimal cut-off value for 
the CD and  CDblinded yielded a sensitivity of approximately 
60% and a specificity of 78% (Table 3). In Fig. 3 the ROC 
curves are shown for the QT-12ECG, QTc-12ECG, CD 
and  CDblinded.
Pilot Study in Foetuses
Fifteen foetuses (n = 7 LQTS and n = 8 controls) were 
included in the pilot study with a total of 24 echocar-
diograms (Supplementary Table 2). The  CDblinded and 
CL could be determined in all cTDI recordings by both 
observers. The intra-observer validity for the determina-
tion of the  CDblinded was high (r = 0.79 and ICC = 0.88 
both P < 0.001) with a systematic error of 4 ms (maximal 
difference 69 ms) and the inter-observer validity was good 
(rho = 0.68, P < 0.001 and ICC = 0.71, P = 0.002) with a 
systematic error of 16 ms (maximal difference 87 ms). For 
the CL, the intra-observer validity was very high (r = 0.87 
and ICC = 0.93 both P < 0.001) with a systematic error of 
8 ms (maximal difference 45 ms) and the inter-observer 
validity was high (r = 0.74 and ICC = 0.84 both P < 0.001) 
with a systematic error of 11 ms (maximal difference 
68 ms).
The first echocardiogram of the LQTS foetuses was 
compared to the first echocardiogram of the controls (to 
avoid including multiple measurements per foetus). There 
was a longer  CDblinded in LQTS foetuses compared to 
controls with an absolute mean difference of 12 ms. The 
CL was also longer in LQTS patients compared to con-
trols (∆10 ms). When the last available echocardiograms 
were included, there also was a longer  CDblinded in LQTS 
foetuses compared to controls (∆35 ms) and a longer CL 
(∆50 ms). Figure 4 shows an example of the difference 
in  CDblinded in foetal twins where one foetus was healthy 
and the other had LQTS type 3. Note that in the two right 
panels the configuration of the velocity curves is inverted 
compared to the curves in children, due to the vertex posi-
tion of the foetuses.
Table 3  Area under the curve 
(AUC), cut-off values with 
corresponding sensitivity and 
specificity in children
CI confidence interval, QT-12ECG QT-interval on the  12-lead ECG, QTc-12ECG QTc-interval on 
the 12-lead ECG, CD myocardial contraction duration measured unblinded for the surface ECG, CDblinded 
myocardial contraction duration measured blinded for the surface ECG, ms milliseconds, NA not applicable
AUC (95% CI) Cut-off value (95% CI) Sensitivity (95% CI) Specificity (95% CI)
QT-12ECG 0.82 (0.50–0.77) 460 ms (NA) 17% (7–29) 100% (100–100)
QTc-12ECG 0.91 (0.66–0.91) 460 ms (NA) 12% (2–22) 100% (100–100)
CD 0.71 (0.47–0.71) 422 ms (371–448) 61% (46–76) 78% (63–90)
CDblinded 0.71 (0.53–0.72) 415 ms (338–442) 56% (41–71) 78% (66–90)
Fig. 3  Receiver-operating characteristic curves of the diagnosis 
LQTS in children for the QT-interval, QTc-interval, CD and  CDblinded




This study is the first to assess abnormal ventricular contrac-
tion patterns in paediatric LQTS patients using cTDI, and 
shows that both the contraction duration and the contrac-
tion duration blinded for a simultaneously recorded ECG 
assessed by cTDI can be used in the identification of LQTS 
in children. In addition, measurements of the contraction 
duration and the contraction duration blinded for a simulta-
neously recorded ECG have a strong correlation and agree-
ment with the QT-interval on a 12-lead ECG and a high 
reproducibility. Moreover, it is feasible to measure the con-
traction duration blinded for a simultaneously recorded ECG 
in foetuses among a broad range of gestational ages making 
it a potential technique for future studies on the diagnostic 
value of the contraction duration blinded for a simultane-
ously recorded ECG for the identification of foetal LQTS.
Mechanical Abnormalities in LQTS
Inhomogeneous prolongation of cardiac repolarization in 
LQTS patients [2] could impact on the regional mechani-
cal cardiac function, since electrical and mechanical cardiac 
functions are inevitably connected via electro-mechanical 
coupling mechanisms [37]. Regional mechanical motion 
can be affected while parameters reflecting global function 
may still be in the normal range. High spatiotemporal reso-
lution techniques are needed to detect such distinct altera-
tions. With this study we showed a prolonged myocardial 
contraction duration in paediatric LQTS patients compared 
to age- and gender-matched controls using cTDI, which 
confirms the results of a recent study in paediatric patients 
by Brado et al [12] where a prolonged myocardial contrac-
tion duration was seen in paediatric LQTS patients using 
MRI. The prolongation of the myocardial contraction in our 
study is in approximately the same order of magnitude as 
described by Haugaa et al. [8] in adult LQTS patients using 
cTDI (about 40 ms) and had a concordant high inter- and 
intra-observer validity. None of the previous studies reported 
data on the diagnostic value of the presence of mechanical 
abnormalities.
Two cases have been reported regarding mechanical 
abnormalities in foetuses,[38, 39] using other modalities 
than cTDI (e.g. Pulsed Doppler). One of the cases was a 
LQTS type 3 foetus with sinus bradycardia, second-degree 
atrioventricular block and transient ventricular tachycardia, 
where a very short transmitral early deceleration time was 
measured by Pulsed Doppler echocardiography [38]. The 
authors suggested that recognition of a short mitral valve 
deceleration time may be helpful in the diagnosis of LQTS 
in the foetus. The other case was a 19-week-old LQTS 
type 1 foetus with a markedly prolonged left ventricular 
Fig. 4  Myocardial contraction 
duration by cTDI in children 
(both upper panels) and in foe-
tuses (both lower panels). Note 
that in the two lower panels the 
configuration of the velocity 
curves is inversed compared to 
the curves in children, due to a 
different position of the foetal 
heart with respect to the probe 
of the echocardiogram
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isovolumetric relaxation time on echocardiogram [39]. The 
measurements performed in these cases, were never vali-
dated in LQTS or correlated to QT-intervals. In a recently 
published multinational study, it was shown that the left 
ventricular isovolumetric relaxation time (LVIRT) is pro-
longed in LQTS foetuses, even when corrected for cycle 
length [40]. In our study we used a validated measurement 
for myocardial contraction duration, as a surrogate for QT-
interval, and an approximation to the combination of the left 
ventricular isovolumetric relaxation time, the left ventricular 
contraction time and the LVIRT. LQTS foetuses seemed to 
have a longer myocardial contraction duration compared to 
controls. Unfortunately, we were not able to test this statisti-
cally due to the small sample size and unstructured collected 
data inherent in a pilot study.
Underlying Mechanism of Mechanical Abnormalities 
in LQTS
It is postulated that a deranged calcium homeostasis may 
play a role in the underlying mechanism of this mechani-
cal dysfunction in LQTS [3, 4, 6–8, 12, 41]. A prolonged 
QT-interval in LQTS implies a prolonged action potential 
duration (APD), and this may increase the calcium influx 
via L-type calcium channel and a concomitant increase in 
the calcium-induced calcium release from the sarcoplasmic 
reticulum. As a consequence the calcium concentration 
may increase in the cytoplasm, and the duration of calcium 
transient may be prolonged, which can cause an impaired 
diastolic relaxation and a prolonged contraction duration. 
The increased or sustained calcium concentration could be 
facilitated by early afterdepolarizations, not reaching thresh-
old for the induction of action potentials, but causing an 
intracellular calcium distortion [3, 4, 7, 8, 11]. Otherwise, 
studies on LQTS type 3 patients suggest that mechanical 
abnormalities may be secondary to an increased intracel-
lular sodium concentration caused by the persistent inward 
sodium current [10, 41, 42].
The inhomogeneous myocardial contraction is related 
to either an heterogeneous distribution of mid-myocardial 
cells (which generally have a longer APD) [8] or ion chan-
nels [11] throughout the myocardium, and reflect electrical 
dispersion [5, 10, 11].
Clinical Implications and Translation to the Foetal 
Heart
Bearing in mind that in this study the LQTS children were 
mainly asymptomatic with not very long QTc-intervals, we 
highlight the potential of the myocardial contraction dura-
tion to detect even subtle mechanical abnormalities in pae-
diatric LQTS patients. The myocardial contraction duration 
has therefore the ability to differentiate between controls 
and phenotype-negative LQTS children. We suggest that 
analysis of mechanical abnormalities might add additional 
information to the diagnosis in paediatric patients suspected 
of LQTS, used along with the QTc-interval on an ECG and 
provocation tests such as an exercise test or a brisk-standing 
test. In any case, the presence of mechanical abnormalities 
can be used in the risk stratification of paediatric LQTS 
patients as shown in previous studies [12].
The accuracy of diagnosing LQTS based on mechani-
cal abnormalities is of a particular interest prenatally. As 
non-invasive tests for the diagnosis of LQTS prenatally are 
limited, and measuring the myocardial contraction duration 
in foetuses seems feasible, the contraction duration blinded 
for a simultaneously recorded ECG could potentially be used 
as a future diagnostic marker for LQTS. However, future 
studies should first focus on further validating measurements 
of the contraction duration blinded for a simultaneously 
recorded ECG in foetuses, and the establishment of normal 
ranges for healthy foetuses. Perhaps in the future, the con-
traction duration blinded for a simultaneously recorded ECG 
measured using cTDI could be used alongside the recog-
nition of sinus bradycardia, second-degree atrioventricular 
block and ventricular arrhythmias in the diagnosis of foetal 
LQTS [26].
Limitations
This study was limited to a small sample size. Previous stud-
ies showed age- and gender-related differences in QTc-inter-
val, [43, 44] and although there are no data available about 
the influences of these factors on mechanical abnormalities, 
it is not inconceivable that the myocardial contraction dura-
tion can be influenced by age and/or gender. For this reason 
LQTS children were age- and gender-matched to controls. 
This resulted in a small sample size but strengthened the 
results of our study because matching removed the potential 
confounding effects of age and gender. Unfortunately, we 
were not able to specify the myocardial contraction duration 
based on genotype due to this small sample size.
As mentioned, only a limited number of symptomatic 
LQTS patients were included in the study, and although we 
performed a bootstrap analysis in order to assign the accu-
racy of myocardial contraction duration estimates, this group 
will be relatively underrepresented. We were therefore not 
able to analyse the presence of mechanical abnormalities 
as a risk factor for cardiac events. Contrariwise, we aimed 
to develop and validate an potential marker for diagnosing 
foetal LQTS, and were not interested in defining risk factors 
for cardiac events.
The slight difference in heart rate (although not statisti-
cally significant), and the presence of beta-blocker therapy in 
LQTS children might influence the myocardial contraction 
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duration. Since there is no method to correct the myocardial 
contraction duration for heart rate, as there is for the QT-
interval on a 12-lead ECG, we corrected using a multiple 
linear regression. Future experiments should elucidate the 
exact relationship between the CD and heart rate to estab-
lish an adequate correction formula. Most of the included 
patients were on beta-blocker therapy according to the 
guidelines, [13] which did not allow us to compare patients 
without beta-blocker therapy to controls. However, Haugaa 
et al. [8] showed that the prolonged contraction duration in 
LQTS was not attributable to the use of beta-blocker therapy.
Conclusion
Myocardial contraction duration assessed by cTDI was 
prolonged in LQTS children and can be used in the iden-
tification of LQTS. Measuring the contraction duration in 
foetuses seems feasible, and a prolonged contraction dura-
tion may therefore be a potential marker for the prenatal 
diagnosis of LQTS in future. Further studies are required 
to support the measurement of the myocardial contraction 
duration as a diagnostic approach for foetal LQTS.
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